The conversation about body composition in the GLP-1 era has centered almost entirely on muscle. That focus is reasonable, but it is incomplete. Weight loss also increases bone turnover and reduces bone mineral density (BMD), along with measures of bone quality such as microarchitecture, geometry, and strength.1 Muscle can be rebuilt relatively quickly with loading and protein. Bone is slower, and in some populations, it may not come back at all.
A new review by Shapses and McGuire (2026) in Current Osteoporosis Reports brings together three decades of work on how and why the skeleton responds to caloric restriction.1 Its practical recommendations are familiar: adequate calcium and protein, and exercise. What is less familiar, and more useful for practitioners, is the pattern that emerges when the mechanisms are read side by side. Almost none of them describe a simple shortage of raw material. They describe changes in signaling. This article examines weight-loss-induced bone loss through that lens and considers what it means for clinical planning.
The Scale of the Problem
The losses are modest in any single episode but clinically meaningful in aggregate. According to the review, a 5% to 10% reduction in body weight is associated with roughly a 1% to 2.5% loss of total hip BMD, and severe caloric restriction produces approximately two and a half times more hip bone loss than moderate restriction. Risk is not evenly distributed. Older adults, postmenopausal women, and individuals who begin weight loss at a lower body weight lose the most, as do people losing weight through very low-calorie diets, bariatric surgery, or GLP-based therapies.1
The durability of the loss is a more concerning finding. In postmenopausal women who were followed for two years after a weight-loss intervention, bone lost during weight reduction was not restored in those who subsequently regained weight.2 Adipose tissue returns—bone does not necessarily follow. For patients who cycle through repeated weight-loss attempts, each round may leave body composition less favorable than where it began.
Older adults, postmenopausal women, and individuals who begin weight loss at a lower body weight lose the most, as do people losing weight through very low-calorie diets, bariatric surgery, or GLP-based therapies.
Bone Is a Signal-Reading Tissue
It is common, even among clinicians, to think of the skeleton primarily as a mineral reservoir. That model is accurate as far as it goes, but it leaves out the part that matters most here. Bone is continuously remodeled, and the osteocytes embedded within the mineralized matrix act as a distributed sensing network. They respond to mechanical strain, hormonal status, and systemic mineral demand, and they coordinate the activity of bone-forming osteoblasts and bone-resorbing osteoclasts accordingly.
When body weight falls, nearly every input these cells respond to changes at the same time. Seen this way, weight-loss-induced bone loss is not evidence that the skeleton is failing. It is evidence that the skeleton is responding accurately to the information it receives.
Visit our Regenerative Health & Medicine Resource Center for in-depth, cutting-edge articles on all aspects of bone health for men and women.
Five Signals That Shift During Energy Restriction
1. Mechanical Load
Reduced body mass means reduced skeletal strain. Mechanical stimulation suppresses osteocyte expression of sclerostin, a secreted inhibitor of Wnt signaling and therefore of osteoblastic bone formation.3 Conversely, mechanical unloading increases sclerostin and drives bone loss through antagonism of Wnt/β-catenin signaling.4 Less load does not create a nutrient deficiency. It communicates a lower structural demand, and bone formation is scaled down to match.
2. Estrogen
Adipose tissue is a meaningful site of estrogen production through aromatase activity, particularly after menopause, when ovarian output has declined. Estrogen restrains osteoclastic resorption and supports skeletal maintenance.5 Loss of fat mass therefore removes part of an anti-resorptive signal, which helps explain why postmenopausal women are among the most vulnerable groups. Other endocrine shifts during weight loss, including reductions in leptin and insulin-like growth factor-1 and changes in cortisol, have also been proposed as contributors.6
3. Calcium Balance and Parathyroid Hormone
This is perhaps the most instructive mechanism. The review notes that adults need to absorb roughly 200 mg of calcium per day to offset obligatory losses, yet during caloric restriction net absorption averages closer to 140 mg.1 Energy restriction reduces both calcium intake and the efficiency of its absorption.7 Serum calcium is tightly defended, so parathyroid hormone (PTH) rises and the shortfall is drawn from the skeleton. This is a priority decision rather than a malfunction. Circulating calcium is non-negotiable; the skeletal reserve is negotiable.
4. The Gut
Shifts in gut microbiota composition are increasingly linked to skeletal changes during weight loss.1 The effect is most pronounced after bariatric surgery, where true fractional calcium absorption falls substantially and gut-derived hormonal signaling is altered.8 When delivery changes upstream, the skeleton absorbs the consequences downstream.
5. Rate of Weight Loss
The speed of weight loss is itself a variable. Severe restriction, very low-calorie diets, bariatric procedures, and GLP therapies all produce larger and faster losses, and bone loss scales accordingly.1. The body appears to read rate as information, not merely magnitude.
The GLP-1 Question
Given the scale of GLP-1 receptor agonist use, a natural question is whether these drugs harm bone directly. The review’s interpretation is that bone loss observed with these medications is largely explained by the amount and speed of weight loss rather than by a drug-specific effect.1 The trial evidence is not entirely uniform. In one study, liraglutide (Victoza) appeared to prevent bone loss after diet-induced weight reduction in women.9
A more recent randomized trial is especially useful for practice. After an initial low-calorie diet, adults with obesity were assigned to exercise, liraglutide, both, or placebo for 52 weeks. Liraglutide alone reduced hip and spine BMD relative to exercise, while the combination of exercise and liraglutide preserved BMD despite producing the greatest weight loss.10 The drug did not determine the skeletal outcome on its own. Whether or not the load signal was maintained did.
Response = Input × Terrain
This is where the review aligns closely with the Systems Homeostasis framework. We summarize clinical outcomes as Response = Input × Terrain, where the multiplication sign denotes interaction rather than arithmetic. The Input in this case, a sustained energy deficit, can be nearly identical across patients. The skeletal Response is not. It depends on which Terrain the deficit lands in: age, sex, estrogen status, starting body weight, absorptive capacity, and the degree of mechanical loading.
Several of the mechanisms above map directly onto domains we use to characterize Terrain. Calcium absorption and gut changes reflect Delivery Infrastructure. The defense of serum calcium at the expense of skeletal reserve is a Resource Allocation decision. The PTH and estrogen shifts sit within Regulatory Gating. The effect of speed falls under Temporal Governance. Characterizing these domains before the Input begins allows the practitioner to anticipate the skeletal Response rather than discover it at the first fracture.
Practitioners are helping more people lose more weight, and faster, than at any previous point. That makes it more important, not less, to understand what the body is being told while it happens. Bone loss during weight loss is neither mysterious nor inevitable.
Why Vitamin D Failed and Calcium Worked
Two findings in the review illustrate the principle more clearly than any theory.
The first concerns vitamin D. Circulating vitamin D concentrations tend to rise as weight is lost, and supplementation at 2,000 to 4,000 IU per day added no skeletal benefit during weight loss.1 Vitamin D was not the constraint in these patients, so increasing it changed nothing.
The second concerns calcium. In overweight postmenopausal women undergoing moderate weight reduction, a calcium intake of 1 g per day did not prevent bone loss,11 whereas raising total intake to approximately 1.7 g per day from food and supplements attenuated it.1 The higher intake worked because it addressed the actual constraint: an absorption shortfall that was driving the PTH signal.
Both interventions are nutrients, and both look reasonable on paper. One matched the Terrain and one did not. That distinction is the difference between adding inputs to a protocol and reading a system. Protein fits the same logic. Higher protein intake supports calcium absorption and was associated with reduced spinal bone loss in meta-analysis,1 and higher protein during caloric restriction has been shown to benefit bone geometry and density outcomes in randomized work.12
Exercise remains the most direct countermeasure because it restores the load signal itself. In dieting older adults with obesity, resistance training, alone or combined with aerobic exercise, attenuated the reduction in hip BMD seen with aerobic exercise alone.13
Clinical Implications
Establish the skeletal baseline before weight loss begins: For higher-risk patients, particularly postmenopausal women, older adults, and those starting at lower body weight, a baseline DEXA scan belongs in the initial plan rather than after the first fracture.
Ask which signal is changing, not only which nutrient is missing: Load, estrogen, calcium balance, gut delivery, and rate are all moving at once. A nutrient-only approach addresses one of five.
Match the intervention to the constraint: Adequate calcium delivery, sufficient protein, and progressive resistance or impact loading address real constraints. Adding more of a nutrient that is not limiting, as the vitamin D data show, does not.
Treat rate as a modifiable variable: Faster weight loss carries a skeletal cost. Where clinically appropriate, a more moderate rate may protect bone.
Pair pharmacotherapy with loading: For patients on GLP-1 receptor agonists, the evidence supports making structured exercise part of the protocol rather than an optional addition.10
Plan for the “regain scenario”: Because bone may not recover with regained weight, weight maintenance planning is also skeletal planning.2
Conclusion
Practitioners are helping more people lose more weight faster than at any previous point. That makes it more important, not less, to understand what the body is being told while it happens. Bone loss during weight loss is neither mysterious nor inevitable. It is the predictable result of a regulated system responding correctly to a changing set of signals. When practitioners characterize the Terrain before the Input and address the signals rather than only the supplies, the skeletal Response becomes something that can be anticipated and managed.
References
- Shapses, S. A., & McGuire, B. D. (2026). Why do we lose bone during weight loss: Can it be prevented? Current Osteoporosis Reports. https://doi.org/10.1007/s11914-026-00984-z
- Von Thun, N. L., Sukumar, D., Heymsfield, S. B., & Shapses, S. A. (2014). Does bone loss begin after weight loss ends? Results 2 years after weight loss or regain in postmenopausal women. Menopause, 21(5), 501–508.
- Iepsen, E. W., Lundgren, J. R., Hartmann, B., et al. (2015). GLP-1 receptor agonist treatment increases bone formation and prevents bone loss in weight-reduced obese women. Journal of Clinical Endocrinology & Metabolism, 100(8), 2909–2917.
- Lin, C., Jiang, X., Dai, Z., et al. (2009). Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/β-catenin signaling. Journal of Bone and Mineral Research, 24(10), 1651–1661.
- Khosla, S., Oursler, M. J., & Monroe, D. G. (2012). Estrogen and the skeleton. Trends in Endocrinology & Metabolism, 23(11), 576–581.
- Shapses, S. A., & Riedt, C. S. (2006). Bone, body weight, and weight reduction: What are the concerns? Journal of Nutrition, 136(6), 1453–1456.
- Cifuentes, M., Riedt, C. S., Brolin, R. E., Field, M. P., Sherrell, R. M., & Shapses, S. A. (2004). Weight loss and calcium intake influence calcium absorption in overweight postmenopausal women. American Journal of Clinical Nutrition, 80(1), 123–130.
- Riedt, C. S., Brolin, R. E., Sherrell, R. M., Field, M. P., & Shapses, S. A. (2006). True fractional calcium absorption is decreased after Roux-en-Y gastric bypass surgery. Obesity, 14(11), 1940–1948.
- Robling, A. G., Niziolek, P. J., Baldridge, L. A., et al. (2008). Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. Journal of Biological Chemistry, 283(9), 5866–5875.
- Jensen, S. B. K., Sørensen, V., Sandsdal, R. M., et al. (2024). Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment: A secondary analysis of a randomized clinical trial. JAMA Network Open, 7(6), e2416775.
- Riedt, C. S., Cifuentes, M., Stahl, T., Chowdhury, H. A., Schlussel, Y., & Shapses, S. A. (2005). Overweight postmenopausal women lose bone with moderate weight reduction and 1 g/day calcium intake. Journal of Bone and Mineral Research, 20(3), 455–463.
- Sukumar, D., Ambia-Sobhan, H., Zurfluh, R., et al. (2011). Areal and volumetric bone mineral density and geometry at two levels of protein intake during caloric restriction: A randomized, controlled trial. Journal of Bone and Mineral Research, 26(6), 1339–1348.
- Villareal, D. T., Aguirre, L., Gurney, A. B., et al. (2017). Aerobic or resistance exercise, or both, in dieting obese older adults. New England Journal of Medicine, 376(20), 1943–1955.
About the Author
Rob Lamberton, BSc, FNTP, is a Canadian-trained formulation scientist, clinical consultant, and author. He is the architect of the Systems Homeostasis framework and the Formulation Intelligence Engine (FIE), and the author of Systems Homeostasis & Applied Human Systems Physiology. He has served as an industry consultant and master formulator at Healthspan Formulations since 2010. He can be reached at Rob@roblamberton.com.
